Mayuran Sriskandarajah
Keine laufenden Positionen mehr
Karriereverlauf von Mayuran Sriskandarajah
Ehemalige bekannte Positionen von Mayuran Sriskandarajah
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIVUS, INC. | Direktor/Vorstandsmitglied | 15.09.2015 | 16.01.2017 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Direktor/Vorstandsmitglied | 08.05.2014 | 19.11.2015 |
Independent Dir/Board Member | 08.05.2014 | 19.11.2015 | |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
Sarissa Capital Management LP
Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Gründer | 01.01.2012 | - |
Portfolio Manager-Aktien | 01.01.2012 | - | |
Wasserstein Perella & Co., Inc. | Corporate Officer/Principal | - | - |
VISKASE COMPANIES, INC. | Direktor/Vorstandsmitglied | 28.12.2006 | - |
Ausbildung von Mayuran Sriskandarajah
Brown University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Process Industries | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VISKASE COMPANIES, INC. | Process Industries |
Private Unternehmen | 5 |
---|---|
Wasserstein Perella & Co., Inc. | |
Sarissa Capital Management LP
Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Finance |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
VIVUS, Inc.
VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
- Börse
- Insiders
- Mayuran Sriskandarajah
- Erfahrung